International Consensus Recommendations for Eosinophilic Gastrointestinal Disease Nomenclature.
Classification
Delphi
Eosinophilic Gastroenteritis
Eosinophilic Gastrointestinal Disease
Nomenclature
Journal
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
ISSN: 1542-7714
Titre abrégé: Clin Gastroenterol Hepatol
Pays: United States
ID NLM: 101160775
Informations de publication
Date de publication:
11 2022
11 2022
Historique:
received:
21
12
2021
revised:
28
01
2022
accepted:
07
02
2022
pubmed:
20
2
2022
medline:
2
11
2022
entrez:
19
2
2022
Statut:
ppublish
Résumé
Substantial heterogeneity in terminology used for eosinophilic gastrointestinal diseases (EGIDs), particularly the catchall term "eosinophilic gastroenteritis," limits clinical and research advances. We aimed to achieve an international consensus for standardized EGID nomenclature. This consensus process utilized Delphi methodology. An initial naming framework was proposed and refined in iterative fashion, then assessed in a first round of Delphi voting. Results were discussed in 2 consensus meetings, and the framework was updated and reassessed in a second Delphi vote, with a 70% threshold set for agreement. Of 91 experts participating, 85 (93%) completed the first and 82 (90%) completed the second Delphi surveys. Consensus was reached on all but 2 statements. "EGID" was the preferred umbrella term for disorders of gastrointestinal (GI) tract eosinophilic inflammation in the absence of secondary causes (100% agreement). Involved GI tract segments will be named specifically and use an "Eo" abbreviation convention: eosinophilic gastritis (now abbreviated EoG), eosinophilic enteritis (EoN), and eosinophilic colitis (EoC). The term "eosinophilic gastroenteritis" is no longer preferred as the overall name (96% agreement). When >2 GI tract areas are involved, the name should reflect all of the involved areas. This international process resulted in consensus for updated EGID nomenclature for both clinical and research use. EGID will be the umbrella term, rather than "eosinophilic gastroenteritis," and specific naming conventions by location of GI tract involvement are recommended. As more data are developed, this framework can be updated to reflect best practices and the underlying science.
Sections du résumé
BACKGROUND & AIMS
Substantial heterogeneity in terminology used for eosinophilic gastrointestinal diseases (EGIDs), particularly the catchall term "eosinophilic gastroenteritis," limits clinical and research advances. We aimed to achieve an international consensus for standardized EGID nomenclature.
METHODS
This consensus process utilized Delphi methodology. An initial naming framework was proposed and refined in iterative fashion, then assessed in a first round of Delphi voting. Results were discussed in 2 consensus meetings, and the framework was updated and reassessed in a second Delphi vote, with a 70% threshold set for agreement.
RESULTS
Of 91 experts participating, 85 (93%) completed the first and 82 (90%) completed the second Delphi surveys. Consensus was reached on all but 2 statements. "EGID" was the preferred umbrella term for disorders of gastrointestinal (GI) tract eosinophilic inflammation in the absence of secondary causes (100% agreement). Involved GI tract segments will be named specifically and use an "Eo" abbreviation convention: eosinophilic gastritis (now abbreviated EoG), eosinophilic enteritis (EoN), and eosinophilic colitis (EoC). The term "eosinophilic gastroenteritis" is no longer preferred as the overall name (96% agreement). When >2 GI tract areas are involved, the name should reflect all of the involved areas.
CONCLUSIONS
This international process resulted in consensus for updated EGID nomenclature for both clinical and research use. EGID will be the umbrella term, rather than "eosinophilic gastroenteritis," and specific naming conventions by location of GI tract involvement are recommended. As more data are developed, this framework can be updated to reflect best practices and the underlying science.
Identifiants
pubmed: 35181570
pii: S1542-3565(22)00143-4
doi: 10.1016/j.cgh.2022.02.017
pmc: PMC9378753
mid: NIHMS1795121
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
2474-2484.e3Subventions
Organisme : NIDDK NIH HHS
ID : P30 DK132710
Pays : United States
Organisme : NCATS NIH HHS
ID : U2C TR002818
Pays : United States
Organisme : NIAID NIH HHS
ID : U54 AI117804
Pays : United States
Informations de copyright
Copyright © 2022. Published by Elsevier Inc.
Références
Gut. 2006 Jun;55(6):749-53
pubmed: 16698746
Clin Rev Allergy Immunol. 2019 Oct;57(2):272-285
pubmed: 30903439
Clin Gastroenterol Hepatol. 2021 Oct;19(10):2102-2111
pubmed: 32801015
Clin Gastroenterol Hepatol. 2010 Aug;8(8):669-75; quiz e88
pubmed: 20451664
J Allergy Clin Immunol. 2014 Nov;134(5):1114-24
pubmed: 25234644
J Allergy Clin Immunol. 2022 Mar;149(3):844-853
pubmed: 34953790
Gastroenterology. 2018 Oct;155(4):1022-1033.e10
pubmed: 30009819
J Allergy Clin Immunol Pract. 2021 May;9(5):2050-2059.e20
pubmed: 33440255
Am J Gastroenterol. 2007 Oct;102(10):2300-13
pubmed: 17617209
Dig Dis Sci. 2020 Jul;65(7):2024-2035
pubmed: 31773359
Am J Gastroenterol. 2019 Jun;114(6):984-994
pubmed: 31008735
Gastroenterology. 2020 May;158(6):1789-1810.e15
pubmed: 32359563
N Engl J Med. 2020 Oct 22;383(17):1624-1634
pubmed: 33085861
Clin Gastroenterol Hepatol. 2022 Mar;20(3):535-545.e15
pubmed: 34089846
J Allergy Clin Immunol. 2004 Jan;113(1):11-28; quiz 29
pubmed: 14713902
Arthroscopy. 2018 Feb;34(2):349-351
pubmed: 29413182
Clin Res Hepatol Gastroenterol. 2018 Oct;42(5):483-493
pubmed: 29615329
J Allergy Clin Immunol. 2020 Jan;145(1):255-269
pubmed: 31738990
Am J Gastroenterol. 2014 Aug;109(8):1277-85
pubmed: 24957155
Dig Liver Dis. 2015 Mar;47(3):197-201
pubmed: 25547198
J Pediatr Gastroenterol Nutr. 2020 Oct;71(4):524-529
pubmed: 32541201
Inflamm Intest Dis. 2016 Jul;1(2):63-69
pubmed: 29922659
J Pediatr Gastroenterol Nutr. 2015 Jul;61(1):56-64
pubmed: 25699593
Gastroenterology. 2019 Mar;156(4):838-842
pubmed: 30452923
J Allergy Clin Immunol Pract. 2021 Sep;9(9):3339-3349.e8
pubmed: 34214704
Clin Gastroenterol Hepatol. 2016 Dec;14(12):1842-1844
pubmed: 27112108
Dig Dis Sci. 2019 Aug;64(8):2231-2241
pubmed: 30982212
Gastroenterology. 2020 May;158(6):1776-1786
pubmed: 32359562
J Pediatr Gastroenterol Nutr. 2016 Jan;62(1):36-42
pubmed: 25988554
J Allergy Clin Immunol Pract. 2020 Jun;8(6):1994-2003.e2
pubmed: 32061717